FGF21 and metabolic disease: Therefore, despite the beneficial effects of this factor on lipid metabolism[9] and reducing angiogenesis, it is asserted that tissue resistance to FGF21 in obesity[19], fatty liver, and related metabolic disorders[19,20] are responsible for an increased serum level of FGF21.